EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence

José G Jimenez, Gregory Haft

Research and Reports in Endocrine Disorders · 2014

DOI: 10.2147/rred.s50952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research and Reports in Endocrine Disorders, 2014. Verfasst von José G Jimenez und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jimenez, J. G., & Haft, G. (2014). Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. https://doi.org/10.2147/rred.s50952

Vancouver

Jimenez JG, Haft G. Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. 2014. doi:10.2147/rred.s50952

BibTeX
@article{Jimenez2014,
  author = {Jimenez, José G and Haft, Gregory},
  title = {Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence},
  journal = {Research and Reports in Endocrine Disorders},
  year = {2014},
  doi = {10.2147/rred.s50952}
}
Kostenlos starten →